{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:52:45Z","timestamp":1779907965063,"version":"3.53.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejmech.2023.115563","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T19:16:51Z","timestamp":1686424611000},"page":"115563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Spiroindole-containing compounds bearing phosphonate group of potential Mpro-SARS-CoV-2 inhibitory properties"],"prefix":"10.1016","volume":"258","author":[{"given":"Mohamed S.","family":"Bekheit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva S.","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson M.","family":"Kariuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4407-9745","authenticated-orcid":false,"given":"Adel S.","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115563_bib1","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19) A Review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2023.115563_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112687","article-title":"Potential treatment methods targeting 2019-nCoV infection","volume":"205","author":"Zheng","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115563_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115563_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12967-020-02355-3","article-title":"SARS-CoV-2 RNA polymerase as target for antiviral therapy","volume":"18","author":"Buonaguro","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2023.115563_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/2211-5463.12167","article-title":"Comparative interactomics for virus-human protein-protein interactions: DNA viruses versus RNA viruses","volume":"7","author":"Durmu\u015f","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ejmech.2023.115563_bib6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/2472555220942123","article-title":"RNA-dependent RNA polymerase as a target for COVID-19 drug discovery","volume":"25","author":"Zhu","year":"2020","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.ejmech.2023.115563_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101830","article-title":"SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus","volume":"37","author":"Dhama","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115563_bib9","doi-asserted-by":"crossref","first-page":"43856","DOI":"10.1021\/acsomega.2c04990","article-title":"Green and regioselective approach for the synthesis of 3-substituted indole based 1,2-dihydropyridine and azaxanthone derivatives as a potential lead for SARS-CoV-2 and delta plus mutant virus: DFT and docking studies","volume":"7","author":"Jayabal","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2023.115563_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728896","article-title":"SARS-CoV-2 coronavirus spike protein-induced apoptosis, inflammatory, and oxidative stress responses in THP-1-like-macrophages: potential role of angiotensin-converting enzyme inhibitor (perindopril)","volume":"12","author":"Barhoumi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2023.115563_bib13","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/jmv.27588","article-title":"Omicron variant of SARS\u2010CoV\u20102: genomics, transmissibility, and responses to current COVID\u201019 vaccines","volume":"94","author":"Araf","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejmech.2023.115563_bib14","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.3390\/molecules26247459","article-title":"Coronavirus infection-associated cell death signaling and potential therapeutic targets","volume":"26","author":"Yapasert","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115563_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00894-022-05137-4","article-title":"Indole alkaloids as potential candidates against COVID-19: an in silico study","volume":"28","author":"Mohseni","year":"2022","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.ejmech.2023.115563_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.118775","article-title":"Antiviral activities of 4H-chromen-4-one scaffold-containing flavonoids against SARS\u2013CoV\u20132 using computational and in vitro approaches","volume":"353","author":"Raj","year":"2022","journal-title":"J. Mol. Liquids"},{"key":"10.1016\/j.ejmech.2023.115563_bib20","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3390\/molecules27082523","article-title":"Advances in the development of SARS-CoV-2 Mpro inhibitors","volume":"27","author":"Agost-Beltr\u00e1n","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115563_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115152","article-title":"Development of indolealkylamine derivatives as potential multi-target agents for COVID-19 treatment","volume":"249","author":"Chauhan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115563_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41467-021-20900-6","article-title":"A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"12","author":"Hattori","year":"2021","journal-title":"Nat. Com."},{"key":"10.1016\/j.ejmech.2023.115563_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.drudis.2020.12.005","article-title":"Potential SARS-CoV-2 main protease inhibitors","volume":"26","author":"Banerjee","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.115563_bib24","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.3390\/molecules26133817","article-title":"Search for non-protein protease inhibitors constituted with an indole and acetylene core","volume":"26","author":"Almaraz-Gir\u00f3n","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115563_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106284","article-title":"Identification of potent compounds against SARs-CoV-2: an in-silico based drug searching against Mpro","volume":"151","author":"Hassam","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115563_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.11.024","article-title":"Structural insights into SARS-CoV-2 proteins","volume":"433","author":"Arya","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115563_bib27","article-title":"Metabolomics-based investigation of SARS-CoV-2 vaccination (Sinovac) reveals an immune-dependent metabolite biomarker","volume":"13","author":"He","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2023.115563_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2020.105778","article-title":"One year update on the COVID-19 pandemic: where are we now?","volume":"214","author":"Mishra","year":"2021","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2023.115563_bib29","doi-asserted-by":"crossref","first-page":"14702","DOI":"10.1021\/acs.jmedchem.1c01214","article-title":"Indole chloropyridinyl ester-derived SARS-CoV-2 3CLpro Inhibitors: enzyme inhibition, antiviral efficacy, structure\u2012activity relationship, and X-ray structural studies","volume":"64","author":"Ghosh","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115563_bib30","first-page":"12593","article-title":"Possible treatment and strategies for COVID-19: review and assessment","volume":"24","author":"Trivedi","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2023.115563_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008040","article-title":"iDrug: integration of drug repositioning and drug-target prediction via cross-network embedding","volume":"16","author":"Chen","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2023.115563_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4149\/BLL_2020_115","article-title":"How do arbidol and its analogs inhibit the SARS-CoV-2?","volume":"121","author":"Aktas","year":"2020","journal-title":"Bratislava Med. J."},{"key":"10.1016\/j.ejmech.2023.115563_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202202097","article-title":"Synthesis and biological evaluation of umifenovir analogues as Anti-SARS-CoV-2 agents","volume":"7","author":"Tanaka","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2023.115563_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.060","article-title":"Arbidol monotherapy is superior to lopinavir\/ritonavir in treating COVID-19","volume":"81","author":"Zhu","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.ejmech.2023.115563_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.002","article-title":"Arbidol combined with LPV\/r versus LPV\/r alone against corona virus disease 2019: a retrospective cohort study","volume":"81","author":"Deng","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.ejmech.2023.115563_bib36","first-page":"105","article-title":"Efficacy and safety of Lopinavir\/Ritonavir or Arbidol in adult patients with mild\/moderate COVID-19: an exploratory randomized controlled trial","volume":"1","author":"Li","year":"2020","journal-title":"M\u00e9d."},{"key":"10.1016\/j.ejmech.2023.115563_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.micinf.2020.05.012","article-title":"Arbidol\/IFN-\u03b12b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study","volume":"22","author":"Xu","year":"2020","journal-title":"Microb. Infect."},{"key":"10.1016\/j.ejmech.2023.115563_bib38","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.12998\/wjcc.v9.i25.7350","article-title":"Efficacy of arbidol in COVID-19 patients: a retrospective study","volume":"9","author":"Wei","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.ejmech.2023.115563_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/22221751.2022.2026739","article-title":"Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro","volume":"11","author":"Mao","year":"2022","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejmech.2023.115563_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00018-021-04102-3","article-title":"Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection","volume":"79","author":"Reiter","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2023.115563_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117583","article-title":"COVID-19: melatonin as a potential adjuvant treatment","volume":"250","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2023.115563_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00018-022-04390-3","article-title":"Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels","volume":"79","author":"Cecon","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2023.115563_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107825","article-title":"SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin","volume":"224","author":"Mehrzadi","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2023.115563_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jmv.27312","article-title":"Melatonin effects on sleep quality and outcomes ofCOVID\u201019 patients: an open\u2010label, randomized, controlled trial","volume":"94","author":"Mousavi","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejmech.2023.115563_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijid.2021.10.012","article-title":"The effect of melatonin on thrombosis, sepsis and mortality rate in COVID-19 patients","volume":"114","author":"Hasan","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115563_bib46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11010-021-04325-9","article-title":"Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features","volume":"477","author":"Rommasi","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2023.115563_bib47","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.3390\/molecules27206934","article-title":"Potential therapeutic approach of melatonin against omicron and some other variants of SARS-CoV-2","volume":"27","author":"Begum","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115563_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17883-9","article-title":"Development of spiro-3-indolin-2-one containing compounds of antiproliferative and ant-SARS-CoV-2 properties","volume":"12","author":"Fawazy","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115563_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105131","article-title":"3-Alkenyl-2-oxindoles: synthesis, antiproliferative and antiviral properties against SARS-CoV-2","volume":"114","author":"Girgis","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115563_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113429","article-title":"Synthesis and structure-activity relationship study of novel 3-diethoxyphosphorylfuroquinoline-4,9-diones with potent antitumor efficacy","volume":"219","author":"Modranka","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115563_bib51","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s00044-021-02801-x","article-title":"Efficient synthesis and evaluation of antiviral and antitumor activity of novel 3-phosphonylated thiazolo[3,2-a]oxopyrimidines","volume":"30","author":"Babushkina","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115563_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113211","article-title":"Design, synthesis and biological evaluation of 2-substituted-6-[(4-substituted-1-piperidyl)methyl]-1H-benzimidazoles as inhibitors of ebola virus infection","volume":"214","author":"Bessi\u00e8res","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115563_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202201406","article-title":"Novel curcumin mimics: design, synthesis, biological properties and computational studies of piperidone-piperazine conjugates","volume":"7","author":"Youssef","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2023.115563_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105466","article-title":"Synthesis of aspirin-curcumin mimic conjugates of potential antitumor and anti-SARS-CoV-2 properties","volume":"117","author":"Srour","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115563_bib62","doi-asserted-by":"crossref","first-page":"33761","DOI":"10.1039\/C9RA05661K","article-title":"Synthesis, human topoisomerase II\u03b1 inhibitory properties and molecular modeling studies of anti-proliferative curcumin mimics","volume":"9","author":"Fawzy","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115563_bib63","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2174\/1871520619666190408131639","article-title":"Novel curcumin inspired antineoplastic 1-sulfonyl-4-piperidones: design, synthesis and molecular modeling studies","volume":"19","author":"Fawzy","year":"2019","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115563_bib64","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.3390\/molecules27185923","article-title":"Synthesis of potential antiviral agents for SARS-CoV-2 using molecular hybridization approach","volume":"27","author":"Wyman","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115563_bib65","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1002\/cmdc.202100476","article-title":"New pyrazine conjugates: synthesis, computational studies, and antiviral properties against SARS-CoV-2","volume":"16","author":"Seliem","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115563_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105117","article-title":"New quinoline-triazole conjugates: synthesis, and antiviral properties against SARS-CoV-2","volume":"114","author":"Seliem","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115563_bib67","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1080\/07391102.2020.1805019","article-title":"Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19","volume":"39","author":"Lokhande","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115563_bib68","unstructured":"3CL Protease (SARS-CoV-2) Assay Kit, BPS Bioscience, Catalog #79955-1, 6042 Cornerstone Court West, Ste. B, San Diego CA 92121, San Diego CA 92121. www.bpsbioscience.com."},{"key":"10.1016\/j.ejmech.2023.115563_bib70","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2165\/00003495-200363150-00009","volume":"63","author":"Plosker","year":"2003","journal-title":"Tipranavir, Drugs"},{"key":"10.1016\/j.ejmech.2023.115563_bib71","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2165\/00003495-200868100-00006","article-title":"Tipranavir: a review of its use in the management of HIV infection","volume":"68","author":"Orman","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2023.115563_bib72","doi-asserted-by":"crossref","first-page":"28554","DOI":"10.1039\/C4RA16663A","article-title":"Rational design, synthesis, and 2D-QSAR study of anti-oncological alkaloids against hepatoma and cervical carcinoma","volume":"5","author":"Girgis","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115563_bib73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejmech.2013.01.042","article-title":"Rational design, synthesis and QSAR study of vasorelaxant active 3-pyridinecarbonitriles incorporating 1H-benzimidazol-2-yl function","volume":"63","author":"Nofal","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115563_bib75","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/cmdc.200900288","article-title":"3,5-Bis(benzylidene)-4-oxo-1-phosphonopiperidines and related diethyl esters: potent cytotoxins with multi-drug-resistance reverting properties","volume":"4","author":"Das","year":"2009","journal-title":"ChemMedChem"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423005299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423005299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:54:48Z","timestamp":1759330488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423005299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":60,"alternative-id":["S0223523423005299"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115563","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spiroindole-containing compounds bearing phosphonate group of potential Mpro-SARS-CoV-2 inhibitory properties","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115563"}}